Patents by Inventor Daniel E. Duffy

Daniel E. Duffy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted imidazo ring systems and methods
    Patent number: 9765071
    Abstract: Imidazo ring systems substituted at the 1-position, pharmaceutical compositions containing the compounds, intermediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Grant
    Filed: March 14, 2016
    Date of Patent: September 19, 2017
    Assignee: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: Larry R. Krepski, Joseph F. Dellaria, Jr., Daniel E. Duffy, Matthew R. Radmer, David T. Amos
  • SUBSTITUTED IMIDAZO RING SYSTEMS AND METHODS
    Publication number: 20160194322
    Abstract: Imidazo ring systems substituted at the 1-position, pharmaceutical compositions containing the compounds, intermediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Application
    Filed: March 14, 2016
    Publication date: July 7, 2016
    Inventors: LARRY R. KREPSKI, JOSEPH F. DELLARIA, JR., DANIEL E. DUFFY, MATTHEW R. RADMER, DAVID T. AMOS
  • Substituted imidazo ring systems and methods
    Patent number: 9328110
    Abstract: Imidazo ring systems substituted at the 1-position, pharmaceutical compositions containing the compounds, intermediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Grant
    Filed: March 11, 2014
    Date of Patent: May 3, 2016
    Assignee: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: Larry R. Krepski, Joseph F. Dellaria, Jr., Daniel E. Duffy, Matthew R. Radmer, David T. Amos
  • SUBSTITUTED IMIDAZO RING SYSTEMS AND METHODS
    Publication number: 20140194628
    Abstract: Imidazo ring systems substituted at the 1-position, pharmaceutical compositions containing the compounds, intermediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Application
    Filed: March 11, 2014
    Publication date: July 10, 2014
    Applicant: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: Larry R. Krepski, Joseph F. Dellaria, Jr., Daniel E. Duffy, Matthew R. Radmer, David T. Amos
  • Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
    Patent number: 8697873
    Abstract: Imidazopyridine, imidazoquinoline, and imidazonaphthyridine compounds having an amide substituent at the 1-position, pharmaceutical compositions containing the compounds, intermediates, and methods of making and methods of use of these compounds as immunomodulators, for modulating cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Grant
    Filed: March 24, 2005
    Date of Patent: April 15, 2014
    Assignee: 3M Innovative Properties Company
    Inventors: Larry R. Krepski, Joseph F. Dellaria, Jr., Daniel E. Duffy, David T. Amos, Bernhard M. Zimmermann, William H. Moser
  • Substituted imidazo ring systems and methods
    Patent number: 8691837
    Abstract: Imidazo ring systems substituted at the 1-position, pharmaceutical compositions containing the compounds, intermediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Grant
    Filed: November 24, 2004
    Date of Patent: April 8, 2014
    Assignee: 3M Innovative Properties Company
    Inventors: Larry R. Krepski, Joseph F. Dellaria, Jr., Daniel E. Duffy, Matthew R. Radmer, David T. Amos
  • 1-alkoxy 1H-imidazo ring systems and methods
    Patent number: 7579359
    Abstract: Imidazo-containing compounds (e.g., imidazonaphthyridines, imidazopyridines, imidazoquinolines, and imidazote-trahydroquinolines) with an alkoxy substituent at the 1-position, pharmaceutical compositions containing the compounds and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Grant
    Filed: September 1, 2005
    Date of Patent: August 25, 2009
    Assignee: 3M Innovative Properties Company
    Inventors: Larry R. Krepski, Daniel E. Duffy, John F. Gerster, Joan T. Moseman
  • 1-Alkoxy 1H-Imidazo Ring Systems and Methods
    Publication number: 20090005376
    Abstract: Imidazo-containing compounds (e.g., imidazonaphthyridines, imidazopyridines, imidazoquinolines, and imidazote-trahydroquinolines) with an alkoxy substituent at the 1-position, pharmaceutical compositions containing the compounds and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Application
    Filed: September 1, 2005
    Publication date: January 1, 2009
    Inventors: Larry R. Krepski, Daniel E. Duffy, John F. Gerster, Joan T. Moseman
  • Ether substituted imidazopyridines
    Patent number: 7125890
    Abstract: Imidazopyridine compounds that contain an ether or thioether functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.
    Type: Grant
    Filed: August 11, 2004
    Date of Patent: October 24, 2006
    Assignee: 3M Innovative Properties Company
    Inventors: Joseph F. Dellaria, Kyle J. Lindstrom, Luke T. Dressel, Daniel E. Duffy, Philip D. Heppner, John R. Jacobsen, Joan T. Moseman, William H. Moser, Matthew R. Radmer, Doris Stoermer, Bernhard M. Zimmermann
  • Ether substituted imidazopyridines
    Publication number: 20040010007
    Abstract: Imidazopyridine compounds that contain an ether or thioether functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.
    Type: Application
    Filed: June 6, 2003
    Publication date: January 15, 2004
    Inventors: Joseph F. Dellaria, Kyle J. Lindstrom, Luke T. Dressel, Daniel E. Duffy, Philip D. Heppner, John R. Jacobsen, Joan T. Moseman, William H. Moser, Matthew R. Radmer, Doris Stoermer, Bernhard M. Zimmermann